Volume 10, Issue 5

Search all Rheumatology and Therapy articles

October 2023

Filter by

Volume:

Sort by

Date published:

New to old Old to new

17 articles in this issue

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Ennio Lubrano
Silvia Scriffignano
Fabio Massimo Perrotta
Commentary Open access 03 July 2023 Pages: 1119 - 1125
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Bruce W. Kirkham
Alexander Egeberg
Luis Puig
Review Open access 03 July 2023 Pages: 1127 - 1146
Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis
Barbara J. M. Bergmans
Biniyam Y. Gebeyehu
Esther de Vries
Original Research Open access 26 June 2023 Pages: 1147 - 1165
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
Heide A. Stirnadel-Farrant
Sarowar M. Golam
Mihail Samnaliev
Original Research Open access 03 July 2023 Pages: 1167 - 1182
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
Heide A. Stirnadel-Farrant
Sarowar M. Golam
Mihail Samnaliev
Original Research Open access 03 July 2023 Pages: 1183 - 1197
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
Xiaohui Zhang
Hong Huang
Zhuoli Zhang
Original Research Open access 07 July 2023 Pages: 1199 - 1213
Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process
Rosario García-Vicuña
Xavier Juanola
Estíbaliz Loza
Original Research Open access 14 July 2023 Pages: 1215 - 1240
Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study
Aarti A. Patel
Shannon Allen Ferrante
Arlene Tieng
Original Research Open access 15 July 2023 Pages: 1241 - 1253
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Gerd R. Burmester
Laura C. Coates
Cassandra Kinch
Original Research Open access 17 July 2023 Pages: 1255 - 1276
The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study
Alexandra Z. Sosinsky
Yufei Song
Matt Page
Original Research Open access 17 July 2023 Pages: 1277 - 1295
Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study
Olivier Bruyere
Germain Honvo
Bernard Cortet
Original Research Open access 21 July 2023 Pages: 1297 - 1303
Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
Jacob N. Hunnicutt
Mary Elizabeth Georgiou
Kerry Gairy
Original Research Open access 21 July 2023 Pages: 1305 - 1318
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Beatriz Joven
Raquel Hernández Sánchez
Mercedes Núñez
Original Research Open access 23 July 2023 Pages: 1319 - 1333
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Yoshiya Tanaka
Peter C. Taylor
Tsutomu Takeuchi
Original Research Open access 25 July 2023 Pages: 1335 - 1348
Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
Yvonne M. van der Kraan
Davy Paap
Anneke Spoorenberg
Original Research Open access 31 July 2023 Pages: 1349 - 1368
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
Juan Xiao
Fengqiao Zhou
Anbing Zhang
Original Research Open access 01 August 2023 Pages: 1369 - 1383
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
Jessica A. Walsh
Christopher D. Saffore
Andrew Ostor
Original Research Open access 12 August 2023 Pages: 1385 - 1398

Volume 10, Issue 5

Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis

A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis

Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis

Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK

Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK

Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study

Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process

Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study

Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis

The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study

Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study

Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States

Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study

Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate

Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study

PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis

Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis

Navigation